For the first time, adults 60 and older are eligible to receive a vaccine against the respiratory syncytial virus, or RSV. Although many people may have not heard of RSV, it’s worth knowing that ...

INSKEEP: What's happening? STEIN: You know, Steve, this virus, the RSV, which stands for respiratory syncytial virus, tends to surge every winter, just like the flu. And for most people ...

What Is the RSV Vaccine? An RSV vaccine is a shot that protects you from respiratory syncytial virus (RSV), which infects your lungs and respiratory tract. Most cases of RSV are mild, but they can ...

A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and ...

It can also be spread by touching a surface or object that’s come in contact with the virus. Respiratory syncytial virus (RSV) causes a respiratory infection with symptoms like coughing ...

Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

What is Abrysvo used for? Abrysvo (respiratory syncytial virus vaccine) is commonly given to help prevent lower respiratory tract disease (such as pneumonia or bronchiolitis) caused by ...

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and even if you’ve never heard of it before, there’s a very good ...

on Wednesday to recommend that high-risk patients ages 50 to 59 be vaccinated for respiratory syncytial virus (RSV), and also added a new option for meningococcal vaccination. "I don't think I can ...

HOUSTON, Texas (KTRK) -- Respiratory syncytial virus, or RSV, is the leading cause of hospitalizations for infants. It's a major risk for older children, too, and can be dangerous, even life ...

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized against respiratory syncytial virus (RSV). Nirsevimab administration ...